▶ 調査レポート

世界の医薬品用リン脂質市場予測(~2028年):ホスファチジルセリン、ホスファチジルイノシトール、ホスファチジルグリセロール

• 英文タイトル:Global Pharmaceutical Grade Phospholipids Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

GlobalInfoResearchが調査・発行した産業分析レポートです。世界の医薬品用リン脂質市場予測(~2028年):ホスファチジルセリン、ホスファチジルイノシトール、ホスファチジルグリセロール / Global Pharmaceutical Grade Phospholipids Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028 / GIR-22E2075資料のイメージです。• レポートコード:GIR-22E2075
• 出版社/出版日:GlobalInfoResearch / 2022年5月
• レポート形態:英文、PDF、109ページ
• 納品方法:Eメール(2~3営業日)
• 産業分類:化学&材料
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
医薬品用リン脂質市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の医薬品用リン脂質の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx%の成長率で成長すると予想されます。

医薬品用リン脂質市場は種類と用途によって区分されます。2017年~2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・ホスファチジルセリン、ホスファチジルイノシトール、ホスファチジルグリセロール

用途別セグメントは次のように区分されます。
・医薬品、医療、その他

世界の医薬品用リン脂質市場の主要な市場プレーヤーは以下のとおりです。
・Avanti Polar Lipids、Cargill Incorporated、DuPont、Lasenor Emul、Lecico、LIPOID、Ruchi Soya Industries、Unimills、Stern-Wywiol Gruppe、Vav Life Sciences

地域別セグメントは次の地域・国をカバーします。
・北米(米国、カナダ、メキシコ)
・ヨーロッパ(ドイツ、フランス、イギリス、ロシア、イタリア)
・アジア太平洋(日本、中国、韓国、インド、東南アジア、オーストラリア)
・南アメリカ(ブラジル、アルゼンチン、コロンビア)
・中東およびアフリカ(サウジアラビア、UAE、エジプト、南アフリカ)

本調査レポートの内容は計15章あります。
・第1章では、医薬品用リン脂質製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な医薬品用リン脂質メーカーの企業概要、2019年~2022年までの医薬品用リン脂質の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な医薬品用リン脂質メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年~2028年までの地域別医薬品用リン脂質の販売量、売上、成長性を示しています。
・第5、6章では、2017年~2028年までの医薬品用リン脂質の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年~2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年~2028年までの主要地域での医薬品用リン脂質市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および医薬品用リン脂質の産業チェーンを掲載しています。
・第13、14、15章では、医薬品用リン脂質の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報(企業概要、製品概要、販売量、価格、売上):Avanti Polar Lipids、Cargill Incorporated、DuPont、Lasenor Emul、Lecico、LIPOID、Ruchi Soya Industries、Unimills、Stern-Wywiol Gruppe、Vav Life Sciences
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年:ホスファチジルセリン、ホスファチジルイノシトール、ホスファチジルグリセロール
・用途別分析2017年-2028年:医薬品、医療、その他
・医薬品用リン脂質の北米市場規模2017年-2028年:アメリカ、カナダ、メキシコ
・医薬品用リン脂質のヨーロッパ市場規模2017年-2028年:ドイツ、イギリス、フランス、ロシア、イタリア
・医薬品用リン脂質のアジア市場規模2017年-2028年:中国、日本、韓国、インド、東南アジア、オーストラリア
・医薬品用リン脂質の南米市場規模2017年-2028年:ブラジル、アルゼンチン
・医薬品用リン脂質の中東・アフリカ市場規模2017年-2028年:サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Pharmaceutical Grade Phospholipids market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Pharmaceutical Grade Phospholipids market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Pharmaceuticals accounting for % of the Pharmaceutical Grade Phospholipids global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Phosphatidylserine segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Pharmaceutical Grade Phospholipids include Avanti Polar Lipids, Cargill Incorporated, DuPont, Lasenor Emul, and Lecico, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Pharmaceutical Grade Phospholipids market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Phosphatidylserine
Phosphatidylinositol
Phosphatidylglycerol
Market segment by Application can be divided into
Pharmaceuticals
Healthcare
Others
The key market players for global Pharmaceutical Grade Phospholipids market are listed below:
Avanti Polar Lipids
Cargill Incorporated
DuPont
Lasenor Emul
Lecico
LIPOID
Ruchi Soya Industries
Unimills
Stern-Wywiol Gruppe
Vav Life Sciences
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pharmaceutical Grade Phospholipids product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pharmaceutical Grade Phospholipids, with price, sales, revenue and global market share of Pharmaceutical Grade Phospholipids from 2019 to 2022.
Chapter 3, the Pharmaceutical Grade Phospholipids competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pharmaceutical Grade Phospholipids breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Pharmaceutical Grade Phospholipids market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Pharmaceutical Grade Phospholipids.
Chapter 13, 14, and 15, to describe Pharmaceutical Grade Phospholipids sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 Pharmaceutical Grade Phospholipids Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pharmaceutical Grade Phospholipids Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Phosphatidylserine
1.2.3 Phosphatidylinositol
1.2.4 Phosphatidylglycerol
1.3 Market Analysis by Application
1.3.1 Overview: Global Pharmaceutical Grade Phospholipids Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Pharmaceuticals
1.3.3 Healthcare
1.3.4 Others
1.4 Global Pharmaceutical Grade Phospholipids Market Size & Forecast
1.4.1 Global Pharmaceutical Grade Phospholipids Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Pharmaceutical Grade Phospholipids Sales in Volume (2017-2028)
1.4.3 Global Pharmaceutical Grade Phospholipids Price (2017-2028)
1.5 Global Pharmaceutical Grade Phospholipids Production Capacity Analysis
1.5.1 Global Pharmaceutical Grade Phospholipids Total Production Capacity (2017-2028)
1.5.2 Global Pharmaceutical Grade Phospholipids Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Pharmaceutical Grade Phospholipids Market Drivers
1.6.2 Pharmaceutical Grade Phospholipids Market Restraints
1.6.3 Pharmaceutical Grade Phospholipids Trends Analysis
2 Manufacturers Profiles
2.1 Avanti Polar Lipids
2.1.1 Avanti Polar Lipids Details
2.1.2 Avanti Polar Lipids Major Business
2.1.3 Avanti Polar Lipids Pharmaceutical Grade Phospholipids Product and Services
2.1.4 Avanti Polar Lipids Pharmaceutical Grade Phospholipids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Cargill Incorporated
2.2.1 Cargill Incorporated Details
2.2.2 Cargill Incorporated Major Business
2.2.3 Cargill Incorporated Pharmaceutical Grade Phospholipids Product and Services
2.2.4 Cargill Incorporated Pharmaceutical Grade Phospholipids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 DuPont
2.3.1 DuPont Details
2.3.2 DuPont Major Business
2.3.3 DuPont Pharmaceutical Grade Phospholipids Product and Services
2.3.4 DuPont Pharmaceutical Grade Phospholipids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Lasenor Emul
2.4.1 Lasenor Emul Details
2.4.2 Lasenor Emul Major Business
2.4.3 Lasenor Emul Pharmaceutical Grade Phospholipids Product and Services
2.4.4 Lasenor Emul Pharmaceutical Grade Phospholipids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Lecico
2.5.1 Lecico Details
2.5.2 Lecico Major Business
2.5.3 Lecico Pharmaceutical Grade Phospholipids Product and Services
2.5.4 Lecico Pharmaceutical Grade Phospholipids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 LIPOID
2.6.1 LIPOID Details
2.6.2 LIPOID Major Business
2.6.3 LIPOID Pharmaceutical Grade Phospholipids Product and Services
2.6.4 LIPOID Pharmaceutical Grade Phospholipids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Ruchi Soya Industries
2.7.1 Ruchi Soya Industries Details
2.7.2 Ruchi Soya Industries Major Business
2.7.3 Ruchi Soya Industries Pharmaceutical Grade Phospholipids Product and Services
2.7.4 Ruchi Soya Industries Pharmaceutical Grade Phospholipids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Unimills
2.8.1 Unimills Details
2.8.2 Unimills Major Business
2.8.3 Unimills Pharmaceutical Grade Phospholipids Product and Services
2.8.4 Unimills Pharmaceutical Grade Phospholipids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Stern-Wywiol Gruppe
2.9.1 Stern-Wywiol Gruppe Details
2.9.2 Stern-Wywiol Gruppe Major Business
2.9.3 Stern-Wywiol Gruppe Pharmaceutical Grade Phospholipids Product and Services
2.9.4 Stern-Wywiol Gruppe Pharmaceutical Grade Phospholipids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Vav Life Sciences
2.10.1 Vav Life Sciences Details
2.10.2 Vav Life Sciences Major Business
2.10.3 Vav Life Sciences Pharmaceutical Grade Phospholipids Product and Services
2.10.4 Vav Life Sciences Pharmaceutical Grade Phospholipids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Pharmaceutical Grade Phospholipids Breakdown Data by Manufacturer
3.1 Global Pharmaceutical Grade Phospholipids Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Pharmaceutical Grade Phospholipids Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Pharmaceutical Grade Phospholipids
3.4 Market Concentration Rate
3.4.1 Top 3 Pharmaceutical Grade Phospholipids Manufacturer Market Share in 2021
3.4.2 Top 6 Pharmaceutical Grade Phospholipids Manufacturer Market Share in 2021
3.5 Global Pharmaceutical Grade Phospholipids Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Pharmaceutical Grade Phospholipids Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Pharmaceutical Grade Phospholipids Market Size by Region
4.1.1 Global Pharmaceutical Grade Phospholipids Sales in Volume by Region (2017-2028)
4.1.2 Global Pharmaceutical Grade Phospholipids Revenue by Region (2017-2028)
4.2 North America Pharmaceutical Grade Phospholipids Revenue (2017-2028)
4.3 Europe Pharmaceutical Grade Phospholipids Revenue (2017-2028)
4.4 Asia-Pacific Pharmaceutical Grade Phospholipids Revenue (2017-2028)
4.5 South America Pharmaceutical Grade Phospholipids Revenue (2017-2028)
4.6 Middle East and Africa Pharmaceutical Grade Phospholipids Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Pharmaceutical Grade Phospholipids Sales in Volume by Type (2017-2028)
5.2 Global Pharmaceutical Grade Phospholipids Revenue by Type (2017-2028)
5.3 Global Pharmaceutical Grade Phospholipids Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Pharmaceutical Grade Phospholipids Sales in Volume by Application (2017-2028)
6.2 Global Pharmaceutical Grade Phospholipids Revenue by Application (2017-2028)
6.3 Global Pharmaceutical Grade Phospholipids Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Pharmaceutical Grade Phospholipids Sales by Type (2017-2028)
7.2 North America Pharmaceutical Grade Phospholipids Sales by Application (2017-2028)
7.3 North America Pharmaceutical Grade Phospholipids Market Size by Country
7.3.1 North America Pharmaceutical Grade Phospholipids Sales in Volume by Country (2017-2028)
7.3.2 North America Pharmaceutical Grade Phospholipids Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Pharmaceutical Grade Phospholipids Sales by Type (2017-2028)
8.2 Europe Pharmaceutical Grade Phospholipids Sales by Application (2017-2028)
8.3 Europe Pharmaceutical Grade Phospholipids Market Size by Country
8.3.1 Europe Pharmaceutical Grade Phospholipids Sales in Volume by Country (2017-2028)
8.3.2 Europe Pharmaceutical Grade Phospholipids Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Pharmaceutical Grade Phospholipids Sales by Type (2017-2028)
9.2 Asia-Pacific Pharmaceutical Grade Phospholipids Sales by Application (2017-2028)
9.3 Asia-Pacific Pharmaceutical Grade Phospholipids Market Size by Region
9.3.1 Asia-Pacific Pharmaceutical Grade Phospholipids Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Pharmaceutical Grade Phospholipids Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Pharmaceutical Grade Phospholipids Sales by Type (2017-2028)
10.2 South America Pharmaceutical Grade Phospholipids Sales by Application (2017-2028)
10.3 South America Pharmaceutical Grade Phospholipids Market Size by Country
10.3.1 South America Pharmaceutical Grade Phospholipids Sales in Volume by Country (2017-2028)
10.3.2 South America Pharmaceutical Grade Phospholipids Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Pharmaceutical Grade Phospholipids Sales by Type (2017-2028)
11.2 Middle East & Africa Pharmaceutical Grade Phospholipids Sales by Application (2017-2028)
11.3 Middle East & Africa Pharmaceutical Grade Phospholipids Market Size by Country
11.3.1 Middle East & Africa Pharmaceutical Grade Phospholipids Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Pharmaceutical Grade Phospholipids Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Pharmaceutical Grade Phospholipids and Key Manufacturers
12.2 Manufacturing Costs Percentage of Pharmaceutical Grade Phospholipids
12.3 Pharmaceutical Grade Phospholipids Production Process
12.4 Pharmaceutical Grade Phospholipids Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Pharmaceutical Grade Phospholipids Typical Distributors
13.3 Pharmaceutical Grade Phospholipids Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer